UPDATE : Friday, May 29, 2020
상단여백
Opdivo’s indication expanded to esophageal squamous cell carcinoma by Kim Yun-mi 2020-04-16 10:48
Despite Covid-19, voters show highest turnout since 2000 by Shim Hyun-tai 2020-04-15 19:18
‘New algorithm can read age, gender via retinal image’ by Shim Hyun-tai 2020-04-14 17:49
Pasteur, Daewoong to co-develop COVID-19 drug from parasiticide by Shim Hyun-tai 2020-04-14 17:49
‘Stealth transmission could still fuel COVID-19 spread’ by Song Soo-youn 2020-04-14 17:31
라인
What are the odds for successful Invossa trials in US? by Jeong Sae-im 2020-04-14 15:01
New virus cases stay below 30 by Shim Hyun-tai 2020-04-14 14:09
AI model developed to predict survival in prostate cancer patients by Kim Yoon-mi 2020-04-14 11:33
Bio-health industry's exports benefit from COVID-19 by Shim Hyun-tai 2020-04-13 18:16
Celltrion gets antibody candidates neutralizing new coronavirus by Shim Hyun-tai 2020-04-13 18:16
라인
‘Robotic surgery better than laparoscope operation in gastric cancer’ by Kim Yoon-mi 2020-04-13 16:03
Korea’s radiation dose management system sells briskly in Europe by Shim Hyun-tai 2020-04-13 15:44
COVID-19 vaccine trial likely to start in April by Song Soo-youn 2020-04-13 15:44
New virus cases remain below 30 for 5th day by Shim Hyun-tai 2020-04-13 12:30
FDA OKs resumption of phase-3 Invossa trial in US by Jeong Sae-im 2020-04-13 11:58
라인
Myongji Hospital leads Korea’s fight against COVID-19 by Kim Yoon-mi 2020-04-13 10:31
COVID-19 cure rate tops 70% amid slowing new cases by Shim Hyun-tai 2020-04-12 18:05
New virus cases fall below 30 for 1st time in 50 days by Shim Hyun-tai 2020-04-10 18:12
Korean researchers unveil genome map of COVID-19 for 1st time by Shim Hyun-tai 2020-04-10 18:08
Samsung signs contract with Vir to make COVID-19 treatment by Shim Hyun-tai 2020-04-10 18:07
여백
여백
여백
Back to Top